Skip to content
10-Q

Quarterly Report

ANGIOTECH PHARMACEUTICALS INC

0001104659-12-037436

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 15, 2012 12.56M sh
Shares Diluted Q1 2012 · Mar 31, 2012 12.91M sh
Capex Q1 2012 · Mar 31, 2012 $413K
Long Term Debt Q1 2012 · Mar 31, 2012 $325M
Long Term Debt Q1 2012 · Dec 31, 2011 $325M
Short Term Investments Q1 2012 · Mar 31, 2012 $1.86M
Short Term Investments Q1 2012 · Dec 31, 2011 $3.26M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $35.07M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $22.17M
Stockholders Equity Q1 2012 · Mar 31, 2012 $148.45M
Stockholders Equity Q1 2012 · Dec 31, 2011 $146.41M
Current Liabilities Q1 2012 · Mar 31, 2012 $34.24M
Current Liabilities Q1 2012 · Dec 31, 2011 $34.55M
Current Assets Q1 2012 · Mar 31, 2012 $112.55M
Current Assets Q1 2012 · Dec 31, 2011 $96.6M
Total Assets Q1 2012 · Mar 31, 2012 $612.3M
Total Assets Q1 2012 · Dec 31, 2011 $608.11M
Eps Diluted Q1 2012 · Mar 31, 2012 $0.00
Eps Basic Q1 2012 · Mar 31, 2012 $0.00
Sga Expense Q1 2012 · Mar 31, 2012 $17.65M
Rd Expense Q1 2012 · Mar 31, 2012 $1.99M
Operating Income Q1 2012 · Mar 31, 2012 $6.93M
Cost Of Revenue Q1 2012 · Mar 31, 2012 $24.68M
Revenue Q1 2012 · Mar 31, 2012 $60.55M